Scancell Share Discussion Threads

[the real lozan] 18/9/2017 19:07

"May being a month = can be a month .."
May be, but it also 'CAN' fly.!!!

[chelsea35] 18/9/2017 18:04

Agree with that Lozan, not doubting we will get it at all, just the timelines. Odd day today, the bid fell from 12.8 to 12.725, and the ask 13.24 to 12.895 in one tick down.
Must be a hefty sell to come, but MMs still wanting shares? Not so easy to read on a volume of 248!!!

[the real lozan] 18/9/2017 15:46

One could say = "The RISKS here are 'PATENTLY' clear"

[inanaco] 18/9/2017 15:44

May being a month = can be a month ...

[tosh123] 18/9/2017 15:38

????????????????????????? No point debating "may" ... as that can also mean "can"

Surely you mean " no point debating "may" ... as that may also mean " can ".

[tosh123] 18/9/2017 15:35

I don't need to debate the meaning of " can ", the Oxford dictionary already does that most eloquently.

[inanaco] 18/9/2017 15:15

so Tosh and Herbie are One .... LOL

[inanaco] 18/9/2017 15:14

Gazza

No point debating "may" ... as that can also mean "can" .. according to Tosh

so that's best left with Tosh to explain

I see it as may be allowable once the Patent is fully processed as this is not the area of dispute.

[tosh123] 18/9/2017 15:10

Wanderer... that made me laugh out loud... great post.
Sums up in a couple of lines, just how idiotic a certain persons posts are.

[tosh123] 18/9/2017 15:09

Gazza, once again, you are 100% correct, and therefore by definition, the risks are " investment risks " NOT personal risks.
The village idiot has ONCE AGAIN, painted himself into a corner and destroyed his own flawed argument, its like taking candy from a baby. Still, at least he clearly now accepts that his statement is totally misleading and WRONG.

[wanderer1210_0] 18/9/2017 15:07

I wonder where Legal and General have filed these sharesHigh RiskModerate RiskLow Risk or of courseNo RiskI know where my tenner lies lol

[inanaco] 18/9/2017 15:01

Gazza, Its already priced in ... the share knows about the patent today ... its been in an RNS ..

[bermudashorts] 18/9/2017 14:59

Drdobson and Tosh - are you related? Your posting style is very similar.

[inanaco] 18/9/2017 14:59

Tosh who are you preaching to ?? Herbie ?

[gazza] 18/9/2017 14:58

Tosh,
As Inanaco quotes the patent office "MAY be allowable".

When you do a risk assessment you take into account both the likelyhood of the risk and the CONSEQUENCES. As far the Moditope patent goes, even if the likelyhood of being rejected was low, the consequences would be catastrophic as far as the share price goes - ignore this at your peril. AIMO of course.

[inanaco] 18/9/2017 14:56

nice simple post ....

I am sure Legal and General have more advanced investment managers, Than teams of Mr W's ... with gambling habits

[tosh123] 18/9/2017 14:52

Gazza,
you are quite right, until the full patent is granted and registered, there is a risk that it won't be accepted, and for the record " YET AGAIN " , there is a massive amount of investment risk here, as there is with any Baby Bio, or indeed any AIM listed stock.... FACT.
This risk IS NOT personal risk, it is COMPANY risk .... they are two totally separate things, anyone who tries to tell anyone different, clearly knows absolutely nothing.

IP has " potential "... until that " potential " is realised, there are huge risks. As of now, Scancell still falls into the " potential " category.... eg High Risk. That high risk is attributed to the company, NOT to the individual, therefore it is by definition, investment risk.

[wanderer1210_0] 18/9/2017 14:51

Lol Legal and General paid £1.6m for 16m shares, it's akin to us mere mortals putting on a £10 double on the horses. If it comes in, it's a few more quid in the account, if it doesn't there's nothing lost. Wonder why they never went "all in"? PMSL

[inanaco] 18/9/2017 14:42

Early feedback from the European Patent Office suggests that broad patent claims for the Moditope® platform may be allowable

that's good enough for me .... because no dispute on that area.

[inanaco] 18/9/2017 14:37

Gazza, Moditope patent is complex as its a new field, however the broad patent has already been agreed, But Scancell has not stopped at a single patent. Hence quite a bit is being spent on further patents in this area. Clearly legal and general did not consider it an issue ...

[gazza] 18/9/2017 14:31

Inanaco, you said:
"Tosh ... why can i achieve in a sentence that you take half a page over"

I agree, you achieved a great detail in that single sentence (or is it 2?) and highlighted a major risk. You say the value is in the IP protected by patent. The patent for Moditope has not been granted - that is a risk.

So you very successfully argue against yourself - nothing new there!

[inanaco] 18/9/2017 14:29

what that means in practice

Because your reliant on another's opinion, it means you cannot evaluate risk, so you spread the risk across a sector

[tosh123] 18/9/2017 14:08

Just for the record.
Risks are very much associated with your investment, not your personal circumstances.
As with everything, some investments carry more risk than others, hence agency ratings of bonds - shares - banks - and indeed, where bonds are concerned, the relevant yields being offered that reflect the RISK of default / repayment. Most regulated financial instruments carry a clear risk ratio, anyone who says differently clearly doesn't understand the most basic rules. The risks of the investment are calculated by a rating agency, NOT by you personally ... These by definition, are " investment risks ", not personal risk... Personal risks are something completely different.

Does Vodafone carry the same risk as Scancell... No of course it doesn't... There is a clear differential in investment risk.
Having looked at the investment risk, only then can you determine your personal appetite based off the investment risk.